MEDICINE COMPRISING LOW MOLECULAR COMPOUND HAVING TGF-β INHIBITION ACTIVITY

Title:

MEDICINE COMPRISING LOW MOLECULAR COMPOUND HAVING TGF-β INHIBITION ACTIVITY

Document Type and Number:

Japanese Patent JP2004043459

Kind Code:

A

Abstract:

To provide a therapeutic agent for 2 type diabetic nephropathy whose oral administration is possible.

This medicine is the oral therapeutic agent for 2 type diabetic nephropathy and contains a low molecular compound having a molecular weight of 600 or less having TGF (transforming growth factor)-β inhibition activity.

More Like This:

JP5385321	Methods and pharmaceutical compositions for wound healing
WO/1998/014572	NOVEL HUMAN PHOSPHOLEMMAN-LIKE PROTEIN
WO/2004/010146	SCREENING METHOD AND ANTI-TUMOR DRUG CANDIDATE OBTAINED THEREFROM

Inventors:

NAKAGAWA TSUTOMU
TAIJI MUTSUO
ONO KEIICHI

Application Number:

JP2003144418A

Publication Date:

February 12, 2004

Filing Date:

May 22, 2003

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SUMITOMO PHARMA

International Classes:

A61K45/00; A61K31/40; A61P3/10; A61P13/12; (IPC1-7): A61K45/00; A61K31/40; A61P3/10; A61P13/12

Attorney, Agent or Firm:

Yobe

Previous Patent: 4-ARYL-5-HYDROXYISOQUINOLINE DERIVATIVE AND METHOD FOR PRODUCING THE SAME

Next Patent: VEGETABLE POWDER COMPOSITION